Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs

Human recombinant activated factor-VII (rFVIIa) has been used successfully in the treatment of spontaneous intracerebral hemorrhage. In addition, there is increasing interest in its use to treat uncontrolled bleeding of other origins, including trauma. The aim of this study was to evaluate the safet...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhang, Jun, Groff, Robert F., Chen, Xiao-Han, Browne, Kevin D., Huang, Jason, Schwartz, Eric D., Meaney, David F., Johnson, Victoria E., Stein, Sherman C., Rojkjaer, Rasmus, Smith, Douglas H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3979422/
https://ncbi.nlm.nih.gov/pubmed/18291370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2007.12.019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky